Oruka Therapeutics (ORKA) EPS (Basic) Growth (5y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 30.87% |
| Mar 31, 2024 | 40.39% |
| Dec 31, 2023 | 47.04% |
| Sep 30, 2023 | 45.40% |
| Jun 30, 2023 | 48.42% |
| Mar 31, 2023 | 52.21% |
| Dec 31, 2022 | 25.13% |
| Sep 30, 2022 | 16.32% |
| Jun 30, 2022 | 17.91% |
| Mar 31, 2022 | 13.68% |
| Dec 31, 2021 | 2.76% |
| Sep 30, 2021 | 8.34% |
| Jun 30, 2021 | 4.59% |
| Mar 31, 2021 | 3.77% |
| Dec 31, 2020 | -16.85% |
| Sep 30, 2020 | -1.26% |
| Jun 30, 2020 | -1.13% |
| Mar 31, 2020 | 1.82% |
| Dec 31, 2019 | 4.53% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -59.63% |
| Mar 31, 2019 | -70.26% |
| Dec 31, 2018 | -88.82% |
| Sep 30, 2018 | -66.71% |
| Jun 30, 2018 | -33.34% |
| Mar 31, 2018 | -59.47% |
| Dec 31, 2017 | -3.23% |
| Sep 30, 2017 | 1.00% |
| Jun 30, 2017 | -0.69% |
| Mar 31, 2017 | 7.00% |
| Dec 31, 2016 | 30.47% |
| Sep 30, 2016 | -24.57% |
| Jun 30, 2016 | -74.83% |
| Mar 31, 2016 | -9.86% |
| Dec 31, 2015 | -9.24% |
| Sep 30, 2015 | -5.25% |
| Jun 30, 2015 | -21.56% |